Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier

Invitrogen’s board approved a 7-percent raise for CEO Greg Lucier, the company said in a document filed with the US Securities and Exchange Commission this week. Lucier’s new base salary is $975,000 effective Feb. 27 and retroactive to Jan. 1. In 2007, Lucier’s base salary was $910,000, according to a separate SEC filing.